Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
30.15
+0.07 (0.23%)
At close: Feb 18, 2026, 4:00 PM EST
29.57
-0.58 (-1.92%)
After-hours: Feb 18, 2026, 4:29 PM EST
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $3.19 billion as of February 18, 2026. Its market cap has increased by 19.54% in one year.
Market Cap
3.19B
Enterprise Value
2.62B
1-Year Change
19.54%
Ranking
Category
Stock Price
$30.15
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $3.19B, an increase of 319.40%. That is a compound annual growth rate of 33.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 3.19B | 21.50% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | 761.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Centessa Pharmaceuticals | 3.61B |
| Viking Therapeutics | 3.35B |
| Liquidia | 3.32B |
| Alumis | 3.31B |
| Legend Biotech | 3.25B |
| Xenon Pharmaceuticals | 3.21B |
| Arcutis Biotherapeutics | 3.17B |
| Vera Therapeutics | 3.00B |